Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ORTHO CYCLEN-21 | Johnson & Johnson | N-019653 DISCN | 1989-12-29 | 1 products |
ORTHO CYCLEN-28 | Johnson & Johnson | N-019653 DISCN | 1989-12-29 | 1 products, RLD |
ORTHO TRI-CYCLEN | Johnson & Johnson | N-019697 DISCN | 1992-07-03 | 2 products |
ORTHO TRI-CYCLEN LO | Johnson & Johnson | N-021241 DISCN | 2002-08-22 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
estarylla | ANDA | 2024-01-10 |
femynor | ANDA | 2020-12-29 |
meoly milia remover serum | OTC monograph final | 2023-08-17 |
mili | ANDA | 2022-03-25 |
milia remover treatment | C200263 | 2023-11-19 |
mono-linyah | ANDA | 2023-11-29 |
mononessa | New Drug Application | 2019-01-09 |
norgestimate and ethinyl estradiol | ANDA | 2024-01-10 |
nymyo | ANDA | 2020-12-09 |
ortho cyclen ortho tri cyclen | New Drug Application | 2019-05-16 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
amenorrhea | — | D000568 | N91.2 |
female infertility | EFO_0008560 | D007247 | N97 |
uterine hemorrhage | — | D014592 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 157 | 1 | — | 4 | 2 | 164 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 5 | 12 | 7 | 1 | 3 | 24 |
Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | — | 14 | 11 | 1 | 2 | 23 |
Cataract | D002386 | HP_0000518 | H26.9 | 1 | 1 | 1 | 12 | 2 | 17 |
Multidrug-resistant tuberculosis | D018088 | EFO_0007381 | — | — | 7 | 8 | 3 | 3 | 15 |
Contraception | D003267 | — | — | 4 | 2 | 2 | 2 | 3 | 13 |
Pneumonia | D011014 | EFO_0003106 | — | — | 2 | 5 | 3 | 2 | 12 |
Infections | D007239 | EFO_0000544 | — | 5 | 1 | 3 | 1 | 1 | 11 |
Endophthalmitis | D009877 | — | — | 2 | 5 | 3 | 4 | — | 11 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 4 | — | 3 | 3 | — | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Keratitis | D007634 | HP_0000491 | H16 | — | 1 | 5 | — | — | 5 |
Keratoconus | D007640 | EFO_0004223 | H18.6 | 1 | 1 | 1 | — | 3 | 5 |
Community-acquired infections | D017714 | — | — | — | 2 | 3 | — | — | 5 |
Lung diseases | D008171 | HP_0002088 | J98.4 | 2 | 1 | 2 | — | — | 4 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | 2 | — | — | 4 |
Extensively drug-resistant tuberculosis | D054908 | — | — | — | 4 | 4 | — | — | 4 |
Bacterial pneumonia | D018410 | EFO_1001272 | J15.9 | — | — | 3 | — | — | 3 |
Lymphoma | D008223 | — | C85.9 | 1 | — | 1 | — | 1 | 3 |
Sepsis | D018805 | HP_0100806 | A41.9 | — | — | 2 | — | — | 2 |
Abdominal abscess | D018784 | EFO_1001753 | — | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 13 | 1 | — | — | — | 14 |
Neoplasms | D009369 | — | C80 | 2 | 1 | — | — | 1 | 4 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 3 | 1 | — | — | — | 4 |
Osteomyelitis | D010019 | EFO_0003102 | M86 | 1 | 1 | — | — | — | 2 |
Endometriosis | D004715 | EFO_0001065 | N80 | 1 | 1 | — | — | — | 2 |
Cholangitis | D002761 | HP_0030151 | K83.0 | — | 1 | — | — | — | 1 |
Amenorrhea | D000568 | — | N91.2 | — | 1 | — | — | — | 1 |
Hypoxia | D000860 | HP_0012418 | R09.02 | — | 1 | — | — | — | 1 |
Tobacco use disorder | D014029 | — | F17 | — | 1 | — | — | — | 1 |
Metrorrhagia | D008796 | HP_0100608 | N92.1 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 3 | — | — | — | 2 | 5 |
Schizophrenia | D012559 | EFO_0000692 | F20 | 5 | — | — | — | — | 5 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 5 | — | — | — | — | 5 |
Hepatitis c | D006526 | — | B19.2 | 4 | — | — | — | — | 4 |
Asthma | D001249 | EFO_0000270 | J45 | 4 | — | — | — | — | 4 |
Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 4 | — | — | — | — | 4 |
Long qt syndrome | D008133 | HP_0001657 | I45.81 | 1 | — | — | — | 2 | 3 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | 3 | — | — | — | — | 3 |
Dyslipidemias | D050171 | HP_0003119 | — | 3 | — | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pathologic dilatation | D004108 | — | — | — | — | — | — | 3 | 3 |
Regeneration | D012038 | — | — | — | — | — | — | 3 | 3 |
Retinal detachment | D012163 | EFO_0005773 | H33.2 | — | — | — | — | 2 | 2 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | — | — | — | 2 | 2 |
Peritonitis | D010538 | EFO_0008588 | K65 | — | — | — | — | 2 | 2 |
Pneumococcal pneumonia | D011018 | EFO_1001474 | J13 | — | — | — | — | 1 | 1 |
Pneumococcal infections | D011008 | EFO_0000772 | J13 | — | — | — | — | 1 | 1 |
Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | — | 1 | 1 |
Bronchitis | D001991 | — | J40 | — | — | — | — | 1 | 1 |
Aortic dissection | D000784 | — | I71.0 | — | — | — | — | 1 | 1 |
Drug common name | Norgestimate |
INN | norgestimate |
Description | Norgestimate is a steroid ester, a ketoxime and a terminal acetylenic compound. It has a role as a contraceptive drug, a progestin and a synthetic oral contraceptive. |
Classification | Small molecule |
Drug class | progestins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC |
PDB | — |
CAS-ID | 35189-28-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1200934 |
ChEBI ID | 50815 |
PubChem CID | 6540478 |
DrugBank | DB00957 |
UNII ID | C291HFX4DY (ChemIDplus, GSRS) |